This study is currently not recruiting participants.

CC100: Safety and Tolerability of Single Doses

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The primary objective of this study is to assess the safety and tolerability of ascending doses of orally administered CC100 in healthy subjects. The secondary objectives of the study are to determine pharmacokinetics and pharmacodynamics of CC100 in pla

Detailed description of study

The primary objective of this study is to assess the safety and tolerability of ascending doses of orally administered CC100 in healthy subjects. The secondary objectives of the study are to determine pharmacokinetics and pharmacodynamics of CC100 in pla

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Drug Safety
  • Age: 100 years or below
  • Gender: All
Updated on 02 Aug 2013. Study ID: 1303010927

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team